It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Materials with high atomic numbers are part of the composition of dental implant systems. In radiotherapy of oral cavity cancers, an implant can cause dose perturbations that affect target definition, dose calculation, and dose distribution. In consequence, this may result in poor tumor control and higher complications. In this study, we evaluated dose homogeneity when a dental implant replaced a normal tooth. We also aimed to evaluate the concordance of dose calculations with dose measurements.
Materials and methods
In this study, 2 sets of planning CT scans of a phantom with a normal tooth and the same phantom with the tooth replaced by a Z1 TBR dental implant system were used. The implant system was composed of a porcelain-fused-to-metal crown and titanium with a zirconium collar. Three radiotherapy plans were designed when the density of the implant material was corrected to match their elements, or when all were set to the density of water, or when using the default density conversion. Gafchromic EBT-3 films at the level of isocenter and crowns were used for measurements.
Results
At the level of crowns, upstream and downstream dose calculations were reduced when metal kernels were applied (M-plan). Moreover, relatively measured dose distribution patterns were most similar to M-plan. At this level, relative to the non-implanted phantom, mean doses values were higher with the implant (215.93 vs. 192.25), also, new high-dose areas appeared around a low-dose streak forward to the implant (119% vs. 95%).
Conclusions
Implants can cause a high dose to the oral cavity in radiotherapy because of extra scattered radiation. Knowledge of the implant dimensions and defining their material enhances the accuracy of calculations.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Islamic Azad University, Medical Radiation Engineering Department, Science and Research Branch, Tehran, Iran (GRID:grid.411463.5) (ISNI:0000 0001 0706 2472)
2 Iran University of Medical Sciences, Radiation Biology Research Center, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066); Iran University of Medical Sciences, Radiation Oncology Department, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
3 Iran University of Medical Sciences, Radiation Biology Research Center, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066); Iran University of Medical Sciences, Medical Physics Department, School of Medicine, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
4 Iran University of Medical Sciences, Medical Physics Department, School of Medicine, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
5 Iran University of Medical Sciences, Radiation Oncology Department, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
6 University Health Network, Princess Margaret Cancer Center, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428)